Zilebesiran Clinical Trials (2026): 4 Studies for Hypertension & High Cardiovascular Risk

Where to Participate: All Zilebesiran Trial Sites in the U.S. (202 sites across 34 states)

Every actively recruiting Zilebesirantrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

Zilebesiran clinical trials at a glance: phase × recruitment status

Recruiting Zilebesiran clinical trials (1)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

Zilebesiran clinical trials by indication

Zilebesiran pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

All Zilebesiran trials (4)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

Zilebesiran clinical trials: frequently asked questions

How many Zilebesiran clinical trials are there?

4 Zilebesiran clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 3 are marked completed.

Are Zilebesiran clinical trials recruiting in 2026?

Yes — 1 Zilebesiran trial is actively recruiting in 2026, with 202 U.S. sites across 34 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Zilebesiran being studied for?

Zilebesiran is being studied for Hypertension, High Cardiovascular Risk, High Risk Cardiovascular Disease, Mild to Moderate Hypertension. The trials are grouped by indication on this page.

What phase is Zilebesiran in?

Zilebesiran clinical trials span 1 Phase 3, 2 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Zilebesiran clinical trials?

The lead sponsor across the most Zilebesiran trials is Alnylam Pharmaceuticals. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Zilebesiranas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.